Science writers, communicators, media, training, and public relations
A Centenary researcher is off to New Delhi to study the impact on cerebral malaria of the major ingredient of turmeric, curcumin.
Dr Saparna Pai has been awarded an Australian Academy of Science Early-Career Australia-India Fellowship to investigate curcumin’s action on immune cells during malaria infection. The Fellowships were announced by the Academy during the visit to India of the Prime Minister, Julia Gillard.
“The good news is that treatment is now less invasive, of shorter duration, much more effective—and diagnosis doesn’t involve humongous needles,” says Dr Nick Shackel from the Centenary Institute.
Driving along the Pamir Highway in Tajikistan at 4000 m above sea level or through the Mongolian desert is a far cry from working on the genetics of hepatitis C in a laboratory in central Sydney.
But that’s the transition Wil d’Avigdor, a PhD student from the Liver Injury and Cancer Laboratory at the Centenary Institute is about to make in the next few weeks. Read More about On the Mongol Rally to boost the fight against liver disease
After “astonishing” preliminary results from new drugsAs the burden of Hepatitis C (HCV) associated liver failure and liver cancer rises in our community so hepatitis C therapy is undergoing radical and rapid change, says Centenary’s Prof Geoff McCaughan. Read More about Future hepatitis cure rates expected to soar
Australian and Vietnamese medical researchers are meeting in Sydney this week to plan their next move against tuberculosis (TB), a disease that once was Australia’s top killer and still kills 54,000 people each year in Vietnam.
The researchers are coming together in Australia to share their progress and build stronger ties in fighting a disease which threatens Australia through its presence in neighbouring countries.
